Proteomics

Dataset Information

0

KAT8-TurboID labelling proteins


ABSTRACT: V5-TurboID-KAT8-expressing A375 stable cells were treated with biotin and then underwent streptavidin purification and mass spectrometry.

ORGANISM(S): Homo Sapiens

SUBMITTER: Yuanzhong Wu  

PROVIDER: PXD038565 | iProX | Mon Dec 05 00:00:00 GMT 2022

REPOSITORIES: iProX

altmetric image

Publications

Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Wu Yuanzhong Y   Zhou Liwen L   Zou Yezi Y   Zhang Yijun Y   Zhang Meifang M   Xu Liping L   Zheng Lisi L   He Wenting W   Yu Kuai K   Li Ting T   Zhang Xia X   Chen Zhenxuan Z   Zhang Ruhua R   Zhou Penghui P   Zhang Nu N   Zheng Limin L   Kang Tiebang T  

Nature cancer 20230309 3


Immunotherapies targeting the PD-1/PD-L1 axis have become first-line treatments in multiple cancers. However, only a limited subset of individuals achieves durable benefits because of the elusive mechanisms regulating PD-1/PD-L1. Here, we report that in cells exposed to interferon-γ (IFNγ), KAT8 undergoes phase separation with induced IRF1 and forms biomolecular condensates to upregulate PD-L1. Multivalency from both the specific and promiscuous interactions between IRF1 and KAT8 is required for  ...[more]

Similar Datasets

2019-09-25 | PXD015161 | Pride
2023-03-24 | PXD036714 | Pride
2024-07-16 | PXD045081 | Pride
2019-09-26 | PXD015162 | Pride
2022-09-12 | PXD034639 | Pride
2017-07-18 | GSE84502 | GEO
2025-07-15 | PXD066141 |
2024-09-19 | PXD049018 | Pride
2023-05-10 | PXD017085 | Pride
2023-10-13 | PXD036624 | Pride